Genetic effects of cyclophosphamide, ifosfamide and trofosfamide.
D000818:Animals; D002875:Chromosomes; D003520:Cyclophosphamide / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology*; D004331:Drosophila melanogaster / Q000378:metabolism; D004926:Escherichia coli / Q000378:metabolism; D005799:Genes, Dominant; D005804:Genes, Lethal; D006801:Humans; D007069:Ifosfamide / Q000378:metabolism / Q000494:pharmacology*; D051379:Mice; D009153:Mutagens; D009154:Mutation; D009588:Nitrogen Mustard Compounds / Q000494:pharmacology*; D010078:Oxazines / Q000494:pharmacology; D010944:Plants / Q000378:metabolism; D011995:Recombination, Genetic; D012441:Saccharomyces cerevisiae / Q000378:metabolism; D012486:Salmonella typhimurium / Q000378:metabolism; D012706:Serratia marcescens / Q000378:metabolism; D014178:Translocation, Genetic
D009153:Mutagens; D009588:Nitrogen Mustard Compounds; D010078:Oxazines; D003520:Cyclophosphamide; C003726:trofosfamide; D007069:Ifosfamide